0 items USD 0.00Search
Your search for "datagroup opera company lines middle east report" gave back 128 results.
There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and...
Catalog:
Rockville Research
February 2018
Price: USD 1,050.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 Summary GBI Research’s latest...
CBR Pharma Insights
June 2017
Price: USD 2,995.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
Catalog:
La Merie Publishing
November 2016
Price: USD 225.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs Summary GBI Research's latest report, "...
CBR Pharma Insights
May 2016
Price: USD 2,995.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
This Competitive Intelligence report about Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS provides a competitor evaluation...
Catalog:
La Merie Publishing
November 2016
Price: USD 560.00
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2016 This Competitive Intelligence report about PD-1 and PD-L1 Immune Checkpoint...
Catalog:
La Merie Publishing
October 2016
Price: USD 450.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
From ages, across industries, laboratories are an integral part of manufacturing and scientific research organizations. The main goal of research and...
Catalog:
IQ4I
April 2015
Price: USD 4,500.00
